Cargando…

Promoting effect of 1,25(OH)(2) vitamin D(3) in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells

We recently reported a new method to purify the induced pluripotent stem (iPS)-derived osteoprogenitors (iPSop). In this paper, we optimized the procedure and characterized cells at each process step. We observed that 10 days of treatment with FGF-2, IGF-1 and TGF-β (FIT) resulted in early-phase ost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Hiroshi, Ochiai-Shino, Hiromi, Onodera, Shoko, Saito, Akiko, Shibahara, Takahiko, Azuma, Toshifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345281/ https://www.ncbi.nlm.nih.gov/pubmed/25652541 http://dx.doi.org/10.1098/rsob.140201

Ejemplares similares

Transplantation of human-induced pluripotent stem cells carried by self-assembling peptide nanofiber hydrogel improves bone regeneration in rat calvarial bone defects
por: Hayashi, Kamichika, et al.
Publicado: (2016)

A Novel Strategy for Enrichment and Isolation of Osteoprogenitor Cells from Induced Pluripotent Stem Cells Based on Surface Marker Combination
por: Ochiai-Shino, Hiromi, et al.
Publicado: (2014)

Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction
por: Hasegawa, Daigo, et al.
Publicado: (2017)

Akt Activation is Required for TGF-β1-Induced Osteoblast Differentiation of MC3T3-E1 Pre-Osteoblasts
por: Suzuki, Eiichi, et al.
Publicado: (2014)

Bone regeneration of induced pluripotent stem cells derived from peripheral blood cells in collagen sponge scaffolds
por: Kato, Hiroshi, et al.
Publicado: (2022)

Stage-dependent differential gene expression profiles of cranial neural crest-like cells derived from mouse-induced pluripotent stem cells
por: Odashima, Ayano, et al.
Publicado: (2019)

Multi-layered mutation in hedgehog-related genes in Gorlin syndrome may affect the phenotype
por: Onodera, Shoko, et al.
Publicado: (2017)

The concurrent stimulation of Wnt and FGF8 signaling induce differentiation of dental mesenchymal cells into odontoblast-like cells
por: Kimura, Motoyoshi, et al.
Publicado: (2021)

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

Vitamin D and 1,25(OH)(2)D Regulation of T cells
por: Cantorna, Margherita T., et al.
Publicado: (2015)

Hedgehog-Related Mutation Causes Bone Malformations with or without Hereditary Gene Mutations
por: Onodera, Shoko, et al.
Publicado: (2023)

Stat3 in osteocytes mediates osteogenic response to loading
por: Corry, Kylie A., et al.
Publicado: (2019)

Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model
por: Saito, Akiko, et al.
Publicado: (2018)

Hedgehog Activation Regulates Human Osteoblastogenesis
por: Onodera, Shoko, et al.
Publicado: (2020)

Gorlin Syndrome: Recent Advances in Genetic Testing and Molecular and Cellular Biological Research
por: Onodera, Shoko, et al.
Publicado: (2020)

1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)(2)D(3) in NSCLC Treatment
por: Upadhyay, Santosh Kumar, et al.
Publicado: (2013)

Osteocytes Specific GSK3 Inhibition Affects In Vitro Osteogenic Differentiation
por: Bertacchini, Jessika, et al.
Publicado: (2018)

Single-cell RNA sequencing identifies Fgf23-expressing osteocytes in response to 1,25-dihydroxyvitamin D(3) treatment
por: Hanai, Ayako, et al.
Publicado: (2023)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

Vitamin D (1,25(OH)(2)D3) induces α-1-antitrypsin synthesis by CD4(+) T cells, which is required for 1,25(OH)(2)D3-driven IL-10
por: Dimeloe, Sarah, et al.
Publicado: (2019)

1,25(OH)(2)D(3) inhibits osteogenic differentiation through activating β-catenin signaling via downregulating bone morphogenetic protein 2
por: Han, Xiaofeng, et al.
Publicado: (2020)

Utilizing Osteocyte Derived Factors to Enhance Cell Viability and Osteogenic Matrix Deposition within IPN Hydrogels
por: Parmentier, Laurens, et al.
Publicado: (2020)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

25(OH)D(3) and 1.25(OH)(2)D(3) inhibits TNF-α expression in human monocyte derived macrophages
por: Rafique, Aisha, et al.
Publicado: (2019)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

25(OH)D-but not 1,25(OH)(2)D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients
por: Zeng, Shufei, et al.
Publicado: (2023)

Generation of two multipotent mesenchymal progenitor cell lines capable of osteogenic, mature osteocyte, adipogenic, and chondrogenic differentiation
por: Prideaux, Matthew, et al.
Publicado: (2021)

Stepwise strategy for generating osteoblasts from human pluripotent stem cells under fully defined xeno-free conditions with small-molecule inducers
por: Zujur, Denise, et al.
Publicado: (2020)

Role of 1,25-Dihydroxyvitamin D(3) on Osteogenic Differentiation and Mineralization of Chicken Mesenchymal Stem Cells
por: Chen, Chongxiao, et al.
Publicado: (2021)

The metabolism of 1,25(OH)(2)D(3) in clinical and experimental kidney disease
por: Turner, Mandy E., et al.
Publicado: (2022)

Without 1α-hydroxylation, the gene expression profile of 25(OH)D(3) treatment overlaps deeply with that of 1,25(OH)(2)D(3) in prostate cancer cells
por: Susa, Takao, et al.
Publicado: (2018)

Super pharmacological levels of calcitriol (1,25-(OH)(2)D(3)) inhibits mineral deposition and decreases cell proliferation in a strain dependent manner in chicken mesenchymal stem cells undergoing osteogenic differentiation in vitro
por: Pande, Vivek V., et al.
Publicado: (2015)

In vitro induction effect of 1,25(OH)(2)D(3) on differentiation of hair follicle stem cell into keratinocyte
por: Joulai Veijouyeh, Sanaz, et al.
Publicado: (2017)

1,25(OH)(2)D(3) Protects Liver Fibrosis Through Decreasing the Generation of TH17 Cells
por: Gu, Lei, et al.
Publicado: (2017)

Anaplastic large cell lymphoma, with 1,25(OH)((2))D((3))-mediated hypercalcemia: A case report
por: Mitobe, Masaki, et al.
Publicado: (2019)

Effects of 1,25(OH)(2)D(3) and 25(OH)D(3) on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy
por: van der Meijden, K., et al.
Publicado: (2016)

Impact of FasL Stimulation on Sclerostin Expression and Osteogenic Profile in IDG-SW3 Osteocytes
por: Kratochvilova, Adela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sha0qs8d88vq129lvkgv6ispmb